Lymphokine production and purification
Abstract
A method for preparing and isolating a transformation vector containing CSF/cDNA is described. The method comprises: preparing RNA from a cell that produces CSF; preparing polyadenylated messenger RNA from said RNA; preparing single stranded cDNA from said messenger RNA; converting the single stranded cDNA to double stranded cDNA; inserting the double stranded cDNA into transformation vectors and transforming bacteria with said vector to form colonies; picking pools of 200 to 500 colonies each and isolating plasmid DNA from each pool; transfecting the plasmid DNA into suitable host cells for expressing CSF protein; culturing the transfected cells and assaying the supernatant for CSF activity; and selecting CSF positive pools and screening the colonies used to make the pool to identify a colony having CSF activity. Also described are a cDNA coding for a protein having CSF activity (i.e. CSF/cDNA), a microorganism or cell line transformed with a recombinant vector containing such CSF/cDNA, and a method for producing CSF protein by expressing said CSF/cDNA by culturing a microorganism or cell line. The invention also provides a method of purifying the CSF proteins and the purified proteins so produced.
Term
Term ended
Projected expiry passed 25 June 2013, 13.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
93 members in 32 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 62834284 | United States of America | A | |
| 62834284 | United States of America | A | |
| 65244784 | United States of America | A | |
| 65244784 | United States of America | A | |
| 65274284 | United States of America | A | |
| 65274284 | United States of America | A | |
| US19840628342 | – | – | – |
| US19840652447 | – | – | – |
| US19840652742 | – | – | – |
Members93
| Document | Office | Kind | |
|---|---|---|---|
| PT80776A | Portugal | A | |
| GR851643B | Greece | B | |
| IL75725D0 | Israel | D0 | |
| IE851695L | Ireland | L | |
| IE930961L | Ireland | L | |
| FI860308A | Finland | A | |
| WO8600639A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4545685A | Australia | A | |
| DK102886A | Denmark | A | |
| DK102886D0 | Denmark | D0 | |
| NO860775L | Norway | L | |
| NO943300L | Norway | L | |
| PL254400A1 | Poland | A1 | |
| HUT38675A | Hungary | A | |
| EP0188479A1 | European Patent Office (EPO) | A1 | |
| KR860700264A | Republic of Korea | A | |
| ES8701226A1 | Spain | A1 | |
| JPS61502682A | Japan | A | |
| ZA855102B | South Africa | B | |
| DE188479T1 | Germany | T1 | |
| PT80776B | Portugal | B | |
| EP0337359A2 | European Patent Office (EPO) | A2 | |
| AU4009089A | Australia | A | |
| EP0337359A3 | European Patent Office (EPO) | A3 | |
| NZ212645A | New Zealand | A | |
| AU599572B2 | Australia | B2 | |
| AU5497690A | Australia | A | |
| KR910001809B1 | Republic of Korea | B1 | |
| PL153139B1 | Poland | B1 | |
| IL94754D0 | Israel | D0 | |
| EP0188479B1 | European Patent Office (EPO) | B1 | |
| AT67244T | Austria | T | |
| ATE67244T1 | Austria | T1 | |
| DE3584089D1 | Germany | D1 | |
| NZ228031A | New Zealand | A | |
| SG108991G | Singapore | G | |
| CY1629A | Cyprus | A | |
| AU628069B2 | Australia | B2 | |
| IL75725A | Israel | A | |
| MY102902A | Malaysia | A | |
| DK59493A | Denmark | A | |
| DK59493D0 | Denmark | D0 | |
| NL930089I1 | Netherlands (Kingdom of the) | I1 | |
| AU644359B2 | Australia | B2 | |
| HU208711B | Hungary | B | |
| LU88337I2This record | Luxembourg | I2 | |
| DK168709B1 | Denmark | B1 | |
| NL930089I2 | Netherlands (Kingdom of the) | I2 | |
| JPH06199897A | Japan | A | |
| IE60819B1 | Ireland | B1 | |
| NO943300D0 | Norway | D0 | |
| HK111594A | Hong Kong, China | A | |
| JPH06319557A | Japan | A | |
| JPH07163351A | Japan | A | |
| NO961452D0 | Norway | D0 | |
| NO961452L | Norway | L | |
| NO179455B | Norway | B | |
| JP2540509B2 | Japan | B2 | |
| NO179455C | Norway | C | |
| NO1996016I1 | Norway | I1 | |
| JP2594743B2 | Japan | B2 | |
| JP2594744B2 | Japan | B2 | |
| JP2594768B2 | Japan | B2 | |
| US5720952A | United States of America | A | |
| US5795568A | United States of America | A | |
| EP0337359B1 | European Patent Office (EPO) | B1 | |
| CZ505985A3 | Czechia | A3 | |
| AT172494T | Austria | T | |
| ATE172494T1 | Austria | T1 | |
| DE3588199D1 | Germany | D1 | |
| US5891429A | United States of America | A | |
| DE3588199T2 | Germany | T2 | |
| US5895646A | United States of America | A | |
| CZ285023B6 | Czechia | B6 | |
| DK172679B1 | Denmark | B1 | |
| RU2130493C1 | Russian Federation | C1 | |
| US5908763A | United States of America | A | |
| CZ289498A3 | Czechia | A3 | |
| HK1011709A1 | Hong Kong, China | A1 | |
| US5942221A | United States of America | A | |
| SK280265B6 | Slovakia | B6 | |
| SK505985A3 | Slovakia | A3 | |
| CZ285625B6 | Czechia | B6 | |
| CA1340852C | Canada | C | |
| NO307348B1 | Norway | B1 | |
| UA29377C2 | Ukraine | C2 | |
| UA39161C2 | Ukraine | C2 | |
| FI108796B | Finland | B | |
| NO314941B1 | Norway | B1 | |
| SA265B1 | Saudi Arabia | B1 | |
| SA94150015B1 | Saudi Arabia | B1 | |
| SA94150015A | Saudi Arabia | A | |
| CA1341618C | Canada | C |
Numbers
- Publication, DOCDB
- 88337
- Publication, EPODOC
- LU88337I
- Application
- 88337
- Application, DOCDB
- 88337
- Application, EPODOC
- LU19930088337C
Titles2
- French
- Leucomax
- English
- Leucomax
Classification
- CPC, 7
- C12N15/85
- C12N15/11
- A61K38/00
- C07K14/535
- C12N15/70
- C12N15/81
- C12N2840/44
- IPC, 31
- A61K35 12
- A61K35 74
- A61K38 00
- A61K38 16
- C07H21 04
- C07K1 16
- C07K1 20
- C07K1 36
- C07K14 00
- C07K14 435
- C07K14 52
- C07K14 53
- C07K14 535
- C12N
- C12N1 19
- C12N1 20
- C12N1 21
- C12N5 00
- C12N5 10
- C12N15 00
- C12N15 09
- C12N15 19
- C12N15 27
- C12N15 70
- C12N15 81
- C12N15 85
- C12P21 00
- C12P21 02
- C12R1 19
- C12R1 865
- C12R1 91